Rchr

J-GLOBAL ID：200901009041115969 Update date: Jun. 06, 2020

Matsunaga Tadashi

マツナガタダシ | Matsunaga Tadashi

Affiliation and department：

Research field (1)： General surgery, pediatric surgery

Research theme for competitive and other funds (2)：

神経芽腫の分化と増殖に関する分子生物学的研究
Study on molecular biology of differentiation and growth in neuroblastomas

MISC (18)：

Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma-report from Japanese study group for Pediatric Liver Tuny-. Pediatr Surg Int. 2003. 19. 142-146
Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma-report from Japanese study group for Pediatric Liver Tuny-. Pediatr Surg Int. 2003. 19. 142-146
F Sasaki, T Matsunaga, M Iwafuchi, Y Hayashi, H Ohkawa, M Ohira, T Okamatsu, T Sugito, Y Tsuchida, A Toyosaka, et al. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor. JOURNAL OF PEDIATRIC SURGERY. 2002. 37. 6. 851-856
Phase I study of irinotecan in pediatric patients with malignant solid tumors. J Pediatr Hematol Oncol. 2002. 24, 2, 94-100
H Takayasu, H Horie, E Hiyama, T Matsunaga, Y Hayashi, Y Watanabe, S Suita, M Kaneko, F Sasaki, K Hashizume, et al. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. CLINICAL CANCER RESEARCH. 2001. 7. 4. 901-908

ｍore...

Education (4)：

- 1993 Chiba University
- 1993 Chiba University Graduate School, Division of Medicine
- 1987 Chiba University School of Medicine
- 1987 Chiba University Faculty of Medicine

Professional career (1)：

(BLANK)

Committee career (1)：

日本小児外科学会評議員,悪性腫瘍委員,庶務委員

Association Membership(s) (7)：

日本小児放射線学会 , 日本新生児学会 , 日本臨床外科学会 , 日本外科科学会 , 日本癌学会 , 日本小児がん学会 , 日本小児外科学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM